05May
[Webinar] Diagnostics, Antibody Testing and Vaccines: Global Outlook on Life Sciences COVID-19 Advances and Evolving Deal Trends - May 7th, 11:00 am - 12:15 pm EDT
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team will examine the current...
By:
McDermott Will & Emery
Related
A new California law requires most companies in our state have at least one woman serve on their boa...
Read More >
Financial institutions M&A sector trends: asset/wealth management — H2 2019 and outlook for 2020 - ...
Read More >
Seyfarth Synopsis: Effective January 1, 2020, AB 5 implements the mandatory “ABC” test for determi...
Read More >
When owners file bankruptcy or projects otherwise go south, lien priority often comes to the forefro...
Read More >
This blog was originally published on July 2, 2019 and revised to include new additional information...
Read More >
On January 6, 2020, Governor Ned Lamont signed bipartisan legislation addressing rates of pay for re...
Read More >